股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
SVA Sinovac Biotech Ltd | -542,894,000.0 | -454,339,000.0 | 2,810,912,000.0 |
GILD 吉利德科學 | 4,309,000,000.0 | 4,168,000,000.0 | 2,264,000,000.0 |
BMY 施貴寶 | 5,591,000,000.0 | 5,267,000,000.0 | 1,597,000,000.0 |
VRTX 福泰製藥 | 1,369,800,000.0 | 1,302,100,000.0 | 657,100,000.0 |
PCVX Vaxcyte Inc | -60,708,000.0 | -98,788,000.0 | 531,734,000.0 |
QGEN Qiagen NV | 182,347,000.0 | 138,031,000.0 | 439,341,000.0 |
ASND Ascendis Pharma A/S | -62,490,080.99 | -63,050,065.86 | 408,375,924.51 |
CVAC CureVac NV | 394,193,723.2 | 390,520,979.49 | 387,812,344.92 |
INCY 英賽德 | 310,871,000.0 | 305,684,000.0 | 316,922,000.0 |
GMAB Genmab A/S | 303,750,530.0 | 296,578,850.0 | 300,463,510.0 |
NUVL Nuvalent Inc | -45,817,000.0 | 291,544,000.0 | |
LEGN Legend Biotech Corp | -75,822,000.0 | -77,887,000.0 | 258,024,000.0 |
IDYA IDEAYA Biosciences Inc | -49,234,000.0 | -49,691,000.0 | 217,234,000.0 |
DAWN Day One Biopharmaceuticals Inc | 50,753,000.0 | 50,029,000.0 | 183,149,000.0 |
TERN Terns Pharmaceuticals Inc | -16,455,000.0 | -16,455,000.0 | 178,640,000.0 |
WVE WAVE Life Sciences Ltd | -46,478,000.0 | -46,861,000.0 | 157,005,000.0 |
ALNY Alnylam Pharmaceuticals Inc | 43,707,000.0 | 39,515,000.0 | 131,305,000.0 |
KROS Keros Therapeutics Inc | -30,500,000.0 | -30,886,000.0 | 125,058,000.0 |
ANAB AnaptysBio Inc | -10,090,000.0 | -10,125,000.0 | 119,760,000.0 |
TGTX TG Therapeutics Inc | -12,205,000.0 | 112,915,000.0 | |
MGNX MacroGenics Inc | 60,162,000.0 | 59,570,000.0 | 95,693,000.0 |
BGNE Beigene Ltd | 188,369,000.0 | 54,714,000.0 | 95,497,000.0 |
VRDN Viridian Therapeutics Inc | -67,706,000.0 | -67,999,000.0 | 92,650,000.0 |
TENX Tenax Therapeutics Inc | -3,087,300.0 | 88,926,910.0 | |
EBS Emergent BioSolutions Inc | 153,700,000.0 | 147,900,000.0 | 85,400,000.0 |
STRO Sutro Biopharma Inc | -64,516,000.0 | -65,344,000.0 | 83,791,000.0 |
REGN 雷傑納榮製藥 | 1,291,200,000.0 | 1,049,300,000.0 | 83,600,000.0 |
PRTC PureTech Health PLC | 25,903,000.0 | 26,148,000.0 | 76,182,000.0 |
LQDA Liquidia Corp | -25,082,000.0 | -26,829,000.0 | 71,275,000.0 |
HRMY Harmony Biosciences Holdings Inc | 70,501,000.0 | 70,498,000.0 | 70,071,000.0 |
ACLX Arcellx Inc | 30,719,000.0 | 28,429,000.0 | 61,821,000.0 |
EXEL Exelixis Inc | 271,338,000.0 | 263,141,000.0 | 59,887,000.0 |
EXAS Exact Sciences Corp | 138,719,000.0 | 67,561,000.0 | 58,650,000.0 |
PHAT Phathom Pharmaceuticals Inc | -63,573,000.0 | -63,617,000.0 | 58,440,000.0 |
CAPR Capricor Therapeutics Inc | -11,642,470.0 | -11,701,500.0 | 57,689,040.0 |
SCPH scPharmaceuticals Inc | -17,424,000.0 | -17,433,000.0 | 52,980,000.0 |
MNMD Mind Medicine (MindMed) Inc | -17,191,000.0 | 52,152,000.0 | |
ZYME Zymeworks Inc | -5,877,000.0 | -6,879,000.0 | 51,393,000.0 |
ARQT Arcutis Biotherapeutics Inc | -34,688,000.0 | -34,831,000.0 | 50,581,000.0 |
LGND Ligand Pharmaceuticals Inc | 36,530,000.0 | 35,934,000.0 | 45,480,000.0 |
GNFT Genfit SA | 47,494,229.42 | 49,373,945.43 | 45,163,639.21 |
RCUS Arcus Biosciences Inc | 26,000,000.0 | 25,000,000.0 | 45,000,000.0 |
KYMR Kymera Therapeutics Inc | -50,190,000.0 | -50,001,000.0 | 43,048,000.0 |
IMMP Immutep Ltd | -10,931,103.9 | -11,331,442.1 | 38,764,598.11 |
APLS Apellis Pharmaceuticals Inc | 34,096,000.0 | 34,096,000.0 | 36,811,000.0 |
VYGR Voyager Therapeutics Inc | -27,968,000.0 | -28,226,000.0 | 36,398,000.0 |
TECH Bio-Techne Corp | 63,889,000.0 | 54,717,000.0 | 35,749,000.0 |
BPMC Blueprint Medicines Corp | -13,637,000.0 | -13,662,000.0 | 35,282,000.0 |
IMTX Immatics NV | -37,550,158.41 | -40,668,483.7 | 34,574,334.24 |
EDIT Editas Medicine Inc | -52,588,000.0 | -55,509,000.0 | 31,391,000.0 |
GNTA Genenta Science SPA | 9,819,234.94 | 9,832,031.18 | 30,702,375.26 |
VSTM Verastem Inc | -23,795,000.0 | -23,795,000.0 | 29,804,000.0 |
KRYS Krystal Biotech Inc | 58,857,000.0 | 57,811,000.0 | 28,180,000.0 |
SNDX Syndax Pharmaceuticals Inc | -62,322,000.0 | 27,623,000.0 | |
RCKT Rocket Pharmaceuticals Inc | -52,103,000.0 | -53,691,000.0 | 26,992,000.0 |
FOLD Amicus Therapeutics Inc | -22,971,000.0 | -23,327,000.0 | 24,463,000.0 |
XAIR Beyond Air Inc | -13,350,000.0 | -14,525,000.0 | 24,287,000.0 |
MGTX MeiraGTx Holdings PLC | -25,022,000.0 | -25,752,000.0 | 24,004,000.0 |
PRAX Praxis Precision Medicines Inc | -27,500,000.0 | 23,502,000.0 | |
OCGN Ocugen Inc | -11,272,000.0 | -11,779,000.0 | 23,002,000.0 |
VTYX Ventyx Biosciences Inc | -35,461,000.0 | -35,461,000.0 | 20,840,000.0 |
MRSN Mersana Therapeutics Inc | -8,577,000.0 | -8,577,000.0 | 19,870,000.0 |
MDXG MiMedx Group Inc | 19,624,000.0 | 19,737,000.0 | 19,764,000.0 |
OLMA Olema Pharmaceuticals Inc | -27,016,000.0 | -27,016,000.0 | 18,996,000.0 |
CDXS Codexis Inc | -12,985,000.0 | -13,991,000.0 | 18,854,000.0 |
PSTX Poseida Therapeutics Inc | -9,594,000.0 | -10,239,000.0 | 18,795,000.0 |
CMPX Compass Therapeutics Inc. | -11,051,000.0 | -11,095,000.0 | 17,965,000.0 |
BNTC Benitec Biopharma Inc | -4,586,000.0 | 16,976,000.0 | |
GLUE Monte Rosa Therapeutics Inc | -20,994,000.0 | -21,393,000.0 | 16,770,000.0 |
DNLI Denali Therapeutics Inc | -59,139,000.0 | -63,023,000.0 | 15,957,000.0 |
KMDA Kamada Ltd | 22,213,000.0 | 20,089,000.0 | 15,454,000.0 |
OPT Opthea Ltd | -91,655,190.0 | -91,684,420.0 | 15,402,430.0 |
ATRA Atara Biotherapeutics Inc | -3,989,000.0 | -3,989,000.0 | 15,139,000.0 |
PGEN Precigen Inc | -22,733,000.0 | -23,615,000.0 | 15,117,000.0 |
IPHA Innate Pharma SA | 38,211,588.45 | 40,434,827.66 | 13,959,924.04 |
SGMO Sangamo Therapeutics Inc | 11,759,000.0 | 11,644,000.0 | 12,915,000.0 |
SPRO Spero Therapeutics Inc | 12,763,000.0 | 12,763,000.0 | |
JANX Janux Therapeutics Inc | -2,231,000.0 | -2,256,000.0 | 12,092,000.0 |
SLS Sellas Life Sciences Group Inc | -7,806,000.0 | -7,806,000.0 | 11,884,000.0 |
AXSM Axsome Therapeutics Inc | -18,631,000.0 | -18,721,000.0 | 11,684,000.0 |
PRQR ProQR Therapeutics NV | -6,297,881.53 | -6,616,282.47 | 11,612,727.99 |
CRIS Curis Inc | -5,936,000.0 | 10,858,000.0 | |
LGVN Longeveron Inc | -2,843,000.0 | -3,323,000.0 | 10,403,000.0 |
CING Cingulate Inc | -3,883,460.0 | -3,742,670.0 | 9,659,220.0 |
CSTL Castle Biosciences Inc | 23,338,000.0 | 16,960,000.0 | 9,387,000.0 |
INZY Inozyme Pharma Inc | -24,528,000.0 | -24,541,000.0 | 9,342,000.0 |
COGT Cogent Biosciences Inc | -51,984,000.0 | -52,264,000.0 | 8,826,000.0 |
RLYB Rallybio Corp | -13,545,000.0 | 8,649,000.0 | |
ANVS Annovis Bio Inc | -3,201,320.0 | 8,638,860.0 | |
MYGN Myriad Genetics Inc | 3,000,000.0 | -3,300,000.0 | 8,600,000.0 |
CERT Certara Inc | 16,987,000.0 | 11,479,000.0 | 8,424,000.0 |
CLRB Cellectar Biosciences Inc | -9,166,880.0 | -9,166,880.0 | 8,394,460.0 |
CMRX Chimerix Inc | -20,508,000.0 | -20,534,000.0 | 7,987,000.0 |
IFRX InflaRx NV | -10,753,557.57 | -10,755,427.89 | 7,852,936.13 |
VIGL Vigil Neuroscience Inc | 4,301,000.0 | 4,301,000.0 | 7,584,000.0 |
PASG Passage Bio Inc | -7,447,000.0 | 7,522,000.0 | |
SNSE Sensei Biotherapeutics Inc | -5,470,000.0 | -5,470,000.0 | 7,240,000.0 |
GOVX GeoVax Labs Inc | -9,297,180.0 | -9,317,830.0 | 7,030,810.0 |
NEO Neogenomics Inc | 9,246,000.0 | -1,553,000.0 | 6,907,000.0 |
NXTC NextCure Inc | -11,454,000.0 | -11,624,000.0 | 6,854,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例